Skip to main content
Premium Trial:

Request an Annual Quote

Munich Leukemia Laboratory Buys Fluidigm Sample Prep Systems

Premium

Fluidigm said today that the Munich Leukemia Laboratory has purchased Access Array and EP1 systems to use with Roche's 454 GS FLX and GS Junior sequencers.

Fluidigm's Access Array will enable researchers at MLL to perform high-throughput targeted deep resequencing analyses; while the EP1 system will be used for rare mutation detection studies and minimal residual disease investigations, Fluidigm said.

Access Array's integrated fluidic circuit facilitates parallel amplification of 48 unique samples, in effect preparing 48 sequencing libraries, in just a few hours, according to Fluidigm. Meantime, the EP1 system enables high-sample-throughput SNP genotyping and end-point digital PCR with extremely low running costs and a simplified workflow for low- to mid-multiplex SNP genotyping, the company said.

MLL combines diagnostic expertise such as cytomorphology, immunophenotyping, molecular genetics, and cytogenetics to provide patients with hematological malignancies with optimized, individualized, and highly reliable diagnoses.

"The number of molecular markers used to categorize myeloid neoplasms is constantly increasing," Torsten Haferlach, co-founder and CEO of MLL, said in a statement. "Amplicon-based next-generation sequencing is a suitable method to accurately detect and quantify the variety of molecular aberrations with high sensitivity. We recently have added next-generation amplicon deep-sequencing to the portfolio of molecular diagnostic tests as part of our daily routine operations."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.